You are cordially invited to join INC Research and Alacrita for a Thought Leadership Luncheon on Thursday November 3, 2016 from 11:00 AM – 1:30 at the Le Meridien -Cambridge.

We welcome Scott Jackson, former CEO of Celator Pharmaceuticals who will be making a special presentation titled \’Managing Through the Complex Waters of AML and Biotech – One Company\’s Success Story.\’

Following Mr. Jackson\’s presentation, our panelists will lead relevant round table discussions targeted to our audiences’ interests;

Seamless Designs: The Impacts On
Sponsor planning
Operations – data and clinical implications for vendors and sites/PI

Impact of Novel Developments (including IO) on Investigators and Trial Participation
Targeted therapies in small % molecular subsets
Combination therapies
FDA initiatives

“Novel” Geographies to Consider for Biotech Phase I/II Oncology Clinical Trials
Special Guest, Eun-Jihn Roh, INC Research Director, Operations Management, Oncology will explain the successes in South Korea

We look forward to seeing you in Cambridge!